National Center for Advancing Translational Sciences; Notice of Closed Meetings, 59934 [2012-24013]
Download as PDF
59934
Federal Register / Vol. 77, No. 190 / Monday, October 1, 2012 / Notices
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 25, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–24014 Filed 9–28–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; NCATS—SEPA Meeting.
Date: October 10–11, 2012.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington DC/Rockville,
1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Carol Lambert, Ph.D.,
Scientific Review Officer, Office of Grants
Management and Review, National Center for
Advancing Translational Sciences, NIH, 6701
Democracy Blvd., Room 1076, Bethesda, MD
20892, 301–435–0814, lambert@mail.nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Div. of Comparative
Medicine Peer Review Meeting; Office of
Research Infrastructure Programs; Div. of
Program Coordination, Planning, and
Strategic Initiatives; Office of the Director.
Date: October 22, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Rockville, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Sheri A. Hild, Ph.D.,
Scientific Review Officer, Office of Grants
VerDate Mar<15>2010
16:48 Sep 28, 2012
Jkt 226001
Management and Review, National Center for
Advancing Translational Sciences, National
Institutes of Health, 6701 Democracy Blvd.,
Room 1082, Bethesda, MD 20892–4874, 301–
435–0811, hildsa@mail.nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; LAM Training Programs—
Div. of Comp. Med. Peer Review Meeting;
Office of Research Infrastructure Programs;
Div. of Program Coordination, Planning, and
Strategic Initiatives; OD.
Date: October 23, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Rockville, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Sheri A. Hild, Ph.D.,
Scientific Review Officer, Office of Grants
Management and Review, National Center for
Advancing Translational Sciences, National
Institutes of Health, 6701 Democracy Blvd.,
Room 1082, Bethesda, MD 20892–4874, 301–
435–0811, hildsa@mail.nih.gov.
Dated: September 25, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–24013 Filed 9–28–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Biology-1.
Date: November 7–8, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Rd.,
Bethesda, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
6116 Executive Blvd., Room 8055A, MSC
8329, Bethesda, MD 20892, 301–402–9415,
zouzhiq@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Biology-2.
Date: November 7–8, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Eun Ah Cho, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Suite 703, Room 7073,
Bethesda, MD 20892, 301–435–1822,
choe@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Community Clinical Oncology Program
Groups (CCOP) (U10).
Date: November 7, 2012.
Time: 8:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Ellen K. Schwartz, EDD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8055B,
Bethesda, MD 20892–8329, 301–594–1215,
schwarel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; MinorityBased Community Clinical Oncology
Program Groups (MB–CCOP) (U10).
Date: November 7, 2012.
Time: 2:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Ellen K. Schwartz, EDD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8055B,
Bethesda, MD 20892–8329, 301–594–1215,
schwarel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Exploratory/Developmental Research
Programs in Cancer Etiology and Genetics.
Date: November 8–9, 2012.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree by Hilton BethesdaWashington DC, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: David G. Ransom, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Room 8133, Bethesda,
MD 20892–8328, 301–451–4757,
david.ransom@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
E:\FR\FM\01OCN1.SGM
01OCN1
Agencies
[Federal Register Volume 77, Number 190 (Monday, October 1, 2012)]
[Notices]
[Page 59934]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24013]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; NCATS--SEPA Meeting.
Date: October 10-11, 2012.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington DC/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Carol Lambert, Ph.D., Scientific Review Officer,
Office of Grants Management and Review, National Center for
Advancing Translational Sciences, NIH, 6701 Democracy Blvd., Room
1076, Bethesda, MD 20892, 301-435-0814, lambert@mail.nih.gov.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; Div. of Comparative Medicine Peer
Review Meeting; Office of Research Infrastructure Programs; Div. of
Program Coordination, Planning, and Strategic Initiatives; Office of
the Director.
Date: October 22, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer,
Office of Grants Management and Review, National Center for
Advancing Translational Sciences, National Institutes of Health,
6701 Democracy Blvd., Room 1082, Bethesda, MD 20892-4874, 301-435-
0811, hildsa@mail.nih.gov.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; LAM Training Programs--Div. of
Comp. Med. Peer Review Meeting; Office of Research Infrastructure
Programs; Div. of Program Coordination, Planning, and Strategic
Initiatives; OD.
Date: October 23, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer,
Office of Grants Management and Review, National Center for
Advancing Translational Sciences, National Institutes of Health,
6701 Democracy Blvd., Room 1082, Bethesda, MD 20892-4874, 301-435-
0811, hildsa@mail.nih.gov.
Dated: September 25, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-24013 Filed 9-28-12; 8:45 am]
BILLING CODE 4140-01-P